These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31748420)

  • 21. Basic, translational and clinical aspects of bronchiectasis in adults.
    Chalmers JD; Elborn S; Greene CM
    Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37286220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymicrobial airway bacterial communities in adult bronchiectasis patients.
    Purcell P; Jary H; Perry A; Perry JD; Stewart CJ; Nelson A; Lanyon C; Smith DL; Cummings SP; De Soyza A
    BMC Microbiol; 2014 May; 14():130. PubMed ID: 24886473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study.
    Gao YH; Guan WJ; Xu G; Lin ZY; Tang Y; Lin ZM; Gao Y; Li HM; Zhong NS; Zhang GJ; Chen RC
    Chest; 2015 Jun; 147(6):1635-1643. PubMed ID: 25412225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.
    Kapur N; Masters IB; Chang AB
    Respir Med; 2009 Nov; 103(11):1681-7. PubMed ID: 19501498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology and genomics of bronchiectasis.
    Perea L; Faner R; Chalmers JD; Sibila O
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 38960613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbations of bronchiectasis.
    De Angelis A; Johnson ED; Sutharsan S; Aliberti S
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 39048130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis.
    Chalmers JD; Hill AT
    Mol Immunol; 2013 Aug; 55(1):27-34. PubMed ID: 23088941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
    Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
    Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary function abnormalities in adult patients with acute exacerbation of bronchiectasis: A retrospective risk factor analysis.
    Ma Y; Niu Y; Tian G; Wei J; Gao Z
    Chron Respir Dis; 2015 Aug; 12(3):222-9. PubMed ID: 25882894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viruses in bronchiectasis: a pilot study to explore the presence of community acquired respiratory viruses in stable patients and during acute exacerbations.
    Mitchell AB; Mourad B; Buddle L; Peters MJ; Oliver BGG; Morgan LC
    BMC Pulm Med; 2018 May; 18(1):84. PubMed ID: 29788952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
    Gompertz S; Bayley DL; Hill SL; Stockley RA
    Thorax; 2001 Jan; 56(1):36-41. PubMed ID: 11120902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
    Laska IF; Crichton ML; Shoemark A; Chalmers JD
    Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention.
    Bell SC; Elborn JS; Byrnes CA
    Respirology; 2018 Nov; 23(11):1006-1022. PubMed ID: 30207018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of viral infections in pulmonary exacerbations of patients with non-cystic fibrosis bronchiectasis: A systematic review.
    Kartsiouni E; Chatzipanagiotou S; Tamvakeras P; Douros K
    Respir Investig; 2022 Sep; 60(5):625-632. PubMed ID: 35811289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchiectasis in Childhood.
    Goyal V; Chang AB
    Clin Chest Med; 2022 Mar; 43(1):71-88. PubMed ID: 35236563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study.
    Mac Aogáin M; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Hassan T; Ong TH; Hui Qi Ng A; Bertrand D; Koh JY; Pang SL; Lee ZY; Gwee XW; Martinus C; Sio YY; Matta SA; Chew FT; Keir HR; Connolly JE; Abisheganaden JA; Koh MS; Nagarajan N; Chalmers JD; Chotirmall SH
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29880655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
    JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences.
    Polverino E; Rosales-Mayor E; Benegas M; Menendez R; Alcaraz-Serrano V; Ansotegui E; Montull B; Girón RM; Cisneros C; Vendrell M; Muñoz G; Marcos MA; Sanchez M; Torres A
    J Infect; 2018 Aug; 77(2):99-106. PubMed ID: 29746946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Shoemark A; Cant E; Carreto L; Smith A; Oriano M; Keir HR; Perea L; Canto E; Terranova L; Vidal S; Moffitt K; Aliberti S; Sibila O; Chalmers JD
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31151955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.